Mifepristone (RU-486 ® ) as a Schedule IV Controlled Drug-Implications for a Misleading Drug Policy on Women's Health Care.
Yi-Ping HsiehYun-Ju WangLing-Yi FengLi-Tzy WuJih-Heng LiPublished in: International journal of environmental research and public health (2022)
Listing mifepristone as a controlled drug could impede the acceptability and accessibility of safe mifepristone use and violates women's right to health care.